Instrument Inactif

Autres langues Adamas Pharmaceuticals, Inc.

Actions

ADMS

US00548A1060

Recherche biotechnologique et médicale

Autres langues

24/11/21	Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K
24/11/21	ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
24/11/21	Adamas Pharmaceuticals, Inc. Announces Management Changes
24/11/21	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from NASDAQ Composite Index
24/11/21	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P TMI Index
24/11/21	Adamas Pharmaceuticals, Inc.(NasdaqGM:ADMS) dropped from S&P Global BMI Index
24/11/21	Supernus Pharmaceuticals, Inc. completed the acquisition of Adamas Pharmaceuticals, Inc. from Mohr Davidow Ventures and others.
23/11/21	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer
11/11/21	Adamas: Q3 Earnings Snapshot
10/11/21	ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
10/11/21	Adamas Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
12/10/21	ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS
12/10/21	Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio - Form 8-K
12/10/21	ADAMAS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
11/10/21	DJ Industrial : US Stocks Drop Monday as Markets Await Big Bank Earnings; Oil Price Advances
11/10/21	Close Update: US Stocks Reverse Earlier Gains as Markets Await Big Bank Earnings; Oil Price Advances
11/10/21	NASDAQ 100 : Top Midday Gainers
11/10/21	DJ Industrial : Equities Stall Midday as Oil Prices Claim Fresh Seven-Year Highs
11/10/21	Midday Report: US Stocks Stall as Oil Prices Claim Fresh Seven-Year Highs
11/10/21	Supernus Pharmaceuticals : to Buy Adamas for $400 Million Upfront Plus Further Boost Based on Parkinson's Disease Drug Sales
11/10/21	DJ Industrial : Wall Street Declines on Soaring Energy Prices
11/10/21	DJ Industrial : Top Premarket Gainers
11/10/21	DJ Industrial : Equities Signal Declines at US Open as Futures Slip Pre-Bell; Europe, Asia Take Mixed Direction
11/10/21	Supernus Pharmaceuticals : to Buy Adamas Pharmaceuticals for up to $9.10 per Share in Cash, Contingent Value Rights Deal
11/10/21	Supernus Pharmaceuticals : bolsters Parkinson's portfolio with $400 mln deal for Adamas Pharma